- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Unjha Formulations Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 7112.0
- ISIN : INE576D01015
-
Today’s Low
21.12 -
Today’s High
23.84

-
Open
23.00 -
Perv Close
21.82 -
52W Low
18.00 -
52W High
39.00
Key Indicators
-
P/E(TTM)
16.14
-
Mar.Cap (₹Cr.)
10.27
-
Div & Yield %
0.00
-
Book Value(₹)
7.41
-
Debt-Equity Ratio
5.04
-
AGM Date
01-Apr-2025
-
EPS
1.42
-
P/E Ratio
16.14
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
10.27
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
4.48
-
BV (₹)
7.40
-
Sales( ₹ in Cr.)
18.50
-
NP (in Cr.)
0.28
-
NP Var(%)
-2.0
-
Div%
0.0
-
CPS (₹)
0.80
-
EPS (₹)
0.60
-
Traded Value (₹ in Lakhs)
9.78
-
52 Week High
39.00
-
52 Week Low
18.00
-
Price BSE
22.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
9.78
-
P/C Ratio
27.50
-
P/E Ratio
35.50
-
Price Vs.BV
0.60
-
12-Mar-2025( 10:13)
Corporate News - Unjha... - Unjha Formulations will hold a...
-
04-Feb-2025( 04:11)
Results - Announcements - Unjha... - Net profit of Unjha Formulatio...
-
17-Jan-2025( 11:04)
Corporate News - Unjha... - Unjha Formulations will hold a...
-
08-Nov-2024( 02:45)
Results - Announcements - Unjha... - Net Loss of Unjha Formulations...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 18.50 | 13.15 | 14.16 | 9.96 | 10.60 | 11.42 |
Excise Duty | 18.50 | 13.15 | 14.16 | 9.96 | 10.60 | 11.42 |
Net Sales | 18.50 | 13.15 | 14.16 | 9.96 | 10.60 | 11.42 |
Other Income | 0.01 | 0.03 | 0.19 | 0.22 | 0.26 | 0.10 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 18.51 | 13.18 | 14.35 | 10.17 | 10.86 | 11.52 |
EXPENDITURE : | ||||||
Raw Materials | 18.50 | 13.15 | 14.16 | 9.96 | 10.60 | 11.42 |
Power & Fuel Cost | 18.50 | 13.15 | 14.16 | 9.96 | 10.60 | 11.42 |
Employee Cost | 0.59 | 0.51 | 0.56 | 0.48 | 0.44 | 0.42 |
Other Manufacturing Expenses | 0.00 | 0.00 | 0.07 | 0.08 | 0.10 | 0.32 |
Selling & Administrative Expenses | 0.85 | 0.72 | 0.56 | 0.72 | 0.56 | 0.72 |
Miscellaneous Expenses | 0.00 | 0.00 | 0.07 | 0.08 | 0.10 | 0.32 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 18.06 | 12.85 | 14.05 | 10.07 | 10.55 | 11.22 |
Operating Profit | 0.93 | 0.79 | 1.18 | 0.99 | 1.04 | 0.90 |
Interest | 0.05 | 0.06 | 0.13 | 0.17 | 0.12 | 0.01 |
Gross Profit | 0.45 | 0.33 | 0.30 | 0.10 | 0.31 | 0.30 |
Depreciation | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 |
Profit Before Tax | 0.45 | 0.33 | 0.30 | 0.10 | 0.31 | 0.30 |
Tax | 0.17 | 0.05 | 0.05 | 0.00 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Net Profit | 0.28 | 0.28 | 0.25 | 0.10 | 0.31 | 0.30 |
Extraordinary Items | 0.45 | 0.33 | 0.30 | 0.10 | 0.31 | 0.30 |
Adjusted Net Profit | 0.28 | 0.28 | 0.25 | 0.10 | 0.31 | 0.30 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | 0.28 | 0.28 | 0.25 | 0.10 | 0.31 | 0.30 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 0.62 | 0.63 | 0.56 | 0.23 | 0.69 | 0.67 |
Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book Value(Adj)-Unit Curr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Background
Unjha Formulations LtdPharmaceuticals - Indian - Formulations
- Unjha Formulations Ltd
- BSE Code : 7112.0
- ISIN : INE576D01015
-
Incorporation Year
1994
-
Registered Office
Khali Char Rasta
State Highway Ta Sidhpur, Patan,
Gujarat-384151 -
Telephone
91-2767-282395
-
FAX
91-2767-282396
-
Chairman
Jashodaben S Patel
-
Managing Director
Krutiben M Patel
-
Company Secretary
Jigar Ray
-
Auditor
Jain & Golechha/Milind Shah & Co
-
Face Value
10
-
Listing
BSE
-
Registrar
Link Intime India Pvt Ltd
5th Floor 506 to 508,
ABC-I Off C G Road ,Navrangpura
Mumbai - Ahmedabad-380009
Unjha Formulations Ltd Peer Comparison
Select | Company Name | LTP (₹) | Revenue | Sales | P/E Ratio | ROCE % |
---|---|---|---|---|---|---|
Unjha Formul. | 22.92 | 18.51 | 18.50 | 16.14 | 10.71 | |
Abbott India | 30,305.85 | 6,097.18 | 5,848.91 | 48.26 | 44.71 | |
Astrazeneca Phar | 8,518.55 | 1,330.33 | 1,295.53 | 219.61 | 33.26 | |
P & G Health Ltd | 5,152.30 | 1,166.89 | 1,151.26 | 36.15 | 39.76 | |
Glaxosmi. Pharma | 2,793.40 | 3,530.73 | 3,407.25 | 55.55 | 44.44 | |
Cipla | 1,444.55 | 17,645.00 | 16,574.34 | 24.77 | 20.10 | |
Amrutanjan Healt | 642.85 | 437.58 | 421.23 | 37.68 | 20.84 | |
Fermenta Biotec. | 285.30 | 315.24 | 307.09 | 27.04 | 4.10 | |
Guj. Themis Bio. | 271.85 | 174.19 | 169.82 | 56.28 | 44.82 | |
Bliss GVS Pharma | 119.25 | 638.96 | 605.46 | 27.29 | 11.19 | |
Ambalal Sarabhai | 36.15 | 11.70 | 3.81 | 15.45 | 1.92 |